Holobiome Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Holobiome Inc. - overview
Location
Boston, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and co-founded by Philip Strandwitz (CEO), Mike La Fleur (President), and Kim Lewis, Holobiome Inc. operates as a biotechnology research company specializing in solving the complexities of the human gut microbiome. In June 2021, the firm raised venture capital led by investor Corundum Systems Biology, Alexandria Venture Investments, and iSelect. The company is focused on discovering and developing therapies from the human microbiome.
The company translates the science of the human microbiome into probiotics and targeted solutions for nervous system disorders and other major whole-body health problems. Holobiome’s product lineup includes probiotics and specialized solutions derived from human gut microbes. Holobiome aims to provide treatments and contribute to improved health outcomes for individuals worldwide.
Current Investors
Alexandria Venture Investments, iSelect Fund Management, Corundum Systems Biology
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.holobiome.org
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.